CARDERO RESOURCE
Research CARDERO RESOURCE (CR5) on Bullrun: market cap EUR 610.81M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCR5
- ExchangeF
- CountrySwitzerland
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 610.81M
- Financial periodQ1 2026
- RevenueCHF 0
- Net income-CHF 28.85M
- Free cash flow-CHF 15.34M
Valuation Snapshot
latest market cap is EUR 610.81M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CHF 0 | -CHF 98.96M | -CHF 67.69M | n/a | -1.92 | CHF 81.33M | CHF 2.31M | CHF 196.07M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | EUR 610.81M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About CARDERO RESOURCE
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is CARDERO RESOURCE's market cap?
CARDERO RESOURCE's market capitalization is EUR 610.81M.
What does CARDERO RESOURCE do?
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally.